| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/05/2015 | WO2015030711A1 New use |
| 03/05/2015 | WO2015030106A1 Compound having ggt inhibitory effect, and ggt-family enzyme inhibitor |
| 03/05/2015 | WO2015029966A1 ω3 UNSATURATED FATTY ACID ENZYME AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID |
| 03/05/2015 | WO2015028960A1 Substituted heterocyclic derivatives as gpr agonists and uses thereof |
| 03/05/2015 | WO2015028941A1 New use |
| 03/05/2015 | WO2015028927A1 Compositions and methods for the treatment of metabolic diseases |
| 03/05/2015 | WO2015028848A1 Bicyclic heterocyclic compounds as multi-kinase inhibitors |
| 03/05/2015 | WO2015027963A1 Aromatic ring derivative, and pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027929A1 Traditional chinese medicine composition |
| 03/05/2015 | WO2015027891A1 New salvianolic acid compound t, preparation method therefor, and use thereof |
| 03/05/2015 | WO2015027730A1 Traditional chinese medicine complex composite significantly increasing serum high density lipoprotein concentration, and preparation method |
| 03/04/2015 | EP2843042A1 Cell preparation containing myocardium-committed cell |
| 03/04/2015 | EP2842969A1 Lactoferrin fusion protein and method for producing same |
| 03/04/2015 | EP2842966A1 Therapeutic agent for injury in epithelium and endothelium |
| 03/04/2015 | EP2842957A1 Method for extracting and separating ginkgolides |
| 03/04/2015 | EP2842948A1 Novel compounds and compositions and methods of use |
| 03/04/2015 | EP2842577A1 Method for proliferating cardiomyocytes using micro-RNA |
| 03/04/2015 | EP2842562A1 The therapeutic use of tetrathiomolybdate |
| 03/04/2015 | EP2842561A1 Enteral environment-improving agent |
| 03/04/2015 | EP2842558A1 Cgrp responsiveness promoter |
| 03/04/2015 | EP2841564A1 Composition and method of stem cells for preservervation of cardiac tissue |
| 03/04/2015 | EP2841457A1 Anti-robo4-antibody |
| 03/04/2015 | EP2841064A1 Use of n-acetylcysteine amide in the treatment of disease and injury |
| 03/04/2015 | EP2841061A1 Methods for treating cardiovascular disorder |
| 03/03/2015 | US8969306 Cyclosporin compositions |
| 03/03/2015 | US8969297 Methods and compositions for the induction of hypothermia |
| 03/03/2015 | US8968783 Hydrogel implants with varying degrees of crosslinking |
| 02/26/2015 | WO2015027206A1 Methods of treating and preventing endothelial dysfunction using bardoxololone methyl or analogs thereof |
| 02/26/2015 | WO2015027146A1 Inhibitors of human 12/15-lipoxygenase |
| 02/26/2015 | WO2015027124A1 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
| 02/26/2015 | WO2015027082A1 Tgf-beta receptor type ii variants and uses thereof |
| 02/26/2015 | WO2015027021A1 Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015026922A1 Alkyl derivatives as sphingosine-1 phosphate receptors modulators |
| 02/26/2015 | WO2015026884A1 Cx3cr1-targeting imaging agents and their use in the diagnosis and treatment of disease |
| 02/26/2015 | WO2015025956A1 Pharmaceutical composition for treating myocardial damage, pharmaceutical composition for preventing myocardial damage, pharmaceutical composition for treating heart failure, pharmaceutical composition for preventing heart failure, method for treating or preventing myocardial damage or heart failure, mfg-e8, uses of mfg-e8, and method for screening compounds for treating or preventing myocardial damage or heart failure |
| 02/26/2015 | WO2015025816A1 Chymase inhibitor and medicine comprising chymase inhibitor |
| 02/26/2015 | WO2015025172A1 5-aryl-thiazol-2-yl-amine compounds and their therapeutic use |
| 02/26/2015 | WO2015025164A1 Amide derivatives as lysophosphatidic acid receptor antagonists |
| 02/26/2015 | WO2015024217A1 Chlorogenic acid powder-injection and preparation method thereof |
| 02/26/2015 | DE112013002717T5 Induktion von Arteriogenese mit einem NO (Stickstoffmonoxid)-Donor Induction of arteriogenesis with an NO (nitric oxide) donor |
| 02/25/2015 | EP2840076A1 Bicyclic compound |
| 02/25/2015 | EP2839843A1 VLA-1 antagonist for use in treating stroke |
| 02/25/2015 | EP2839832A2 Use of dipeptidyl peptidase IV inhibitors |
| 02/25/2015 | EP2838890A1 Fluorinated benzofuran derivatives |
| 02/25/2015 | EP2838883A1 New phenyl-tetrahydroisoquinoline derivatives |
| 02/24/2015 | US8962570 Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism |
| 02/24/2015 | US8962546 Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8962017 Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 02/24/2015 | CA2712078C Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 02/24/2015 | CA2683534C Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same |
| 02/24/2015 | CA2627423C Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 02/24/2015 | CA2594233C Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 02/19/2015 | WO2015023889A1 Rapidly-dissolving thin film formulation of water soluble digitalis glycoside for the treatment of congestive heart disease |
| 02/19/2015 | WO2015022953A1 Blood-brain barrier disorder improvement agent |
| 02/19/2015 | WO2015022546A1 Inhibitors of plasma kallikrein |
| 02/19/2015 | WO2015006830A9 A method for organ arrest, protection and preservation and reducing tissue injury |
| 02/19/2015 | DE102013013796A1 Stoffgemische enthaltend Vitamin B12 zur spezifischen Anwendung für die Behandlung des Raynaud-Syndroms Mixtures comprising vitamin B12 for the specific application for the treatment of Raynaud's syndrome |
| 02/18/2015 | EP2837389A1 Medicinal composition for treating infarction |
| 02/18/2015 | EP2837380A1 Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof |
| 02/18/2015 | EP2836215A1 Composition for prevention of vasoactivity in the treatment of blood loss and anemia |
| 02/18/2015 | EP2836206A2 Controlled release pharmaceutical formulations of direct thrombin inhibitors |
| 02/17/2015 | US8957065 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
| 02/17/2015 | CA2759163C Method for producing olmesartan medoxomil |
| 02/17/2015 | CA2673918C Substituted isoquinoline and isoquinolinone derivatives |
| 02/17/2015 | CA2673916C Substituted isoquinolone and isoquinolinone derivatives as inhibitors of rho-kinase |
| 02/17/2015 | CA2664744C Triphenylphosphonium thionitrite nitric oxide donors |
| 02/17/2015 | CA2647423C Triazolone derivative |
| 02/17/2015 | CA2612176C Dihydrothieno[2,3-d]pyramidine-6-carboxylic acid derivatives as pde9 inhibitors |
| 02/17/2015 | CA2592532C Sesamin/episesamin compositions with improved bioavailability |
| 02/12/2015 | WO2015020191A1 Calcium agent |
| 02/12/2015 | WO2015020139A1 Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nonparticle composition |
| 02/12/2015 | WO2015020138A1 Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same |
| 02/12/2015 | WO2015018858A1 Compositions comprising vitamin k derivatives and salts |
| 02/12/2015 | WO2015018808A1 Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereof |
| 02/12/2015 | WO2015018659A1 Glutamine synthetase inhibitors for inhibition of pathological angiogenesis |
| 02/12/2015 | WO2015018475A1 Piperidine urea derivatives |
| 02/12/2015 | WO2015018333A1 Inhibitors of bruton's tyrosine kinase |
| 02/12/2015 | WO2015018129A1 Antihypertensive chinese medicine preparation and preparation method therefor |
| 02/12/2015 | WO2015018124A1 Traditional chinese medicine preparation for reducing blood pressure and preparation method thereof |
| 02/12/2015 | US20150045552 5ht2c receptor modulators |
| 02/12/2015 | US20150045440 Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
| 02/12/2015 | US20150045375 Novel compounds |
| 02/11/2015 | EP2834233A1 New alpha2 adrenoceptor agonists |
| 02/11/2015 | EP2834220A1 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
| 02/11/2015 | EP2833893A1 Stem cell microparticles |
| 02/11/2015 | CN104350054A 作为选择性细胞周期蛋白依赖性激酶抑制剂的吡唑并-三嗪衍生物 As a selective cyclin-dependent kinase inhibitors pyrazolo - triazine derivative |
| 02/11/2015 | CN104350053A 杂芳族甲基环胺衍生物 Heteroaromatic methyl cyclic amine derivative |
| 02/11/2015 | CN104350052A 一氧化氮供体脑啡肽酶抑制剂 Nitric oxide donor neprilysin inhibitor |
| 02/11/2015 | CN104350045A 用于治疗涉及调节兰诺定受体的调节障碍的活性剂 For the treatment involves adjusting the ryanodine receptor dysregulation of active agent |
| 02/11/2015 | CN104350042A 脑啡肽酶抑制剂 Neprilysin inhibitor |
| 02/11/2015 | CN104349790A 用于治疗糖尿病的葡萄糖激酶活化剂组合物 For treating diabetes glucokinase activator composition |
| 02/11/2015 | CN104349778A 在失血和贫血治疗中用于防止血管活性的组合物 Compositions in the treatment of blood loss and anemia for preventing vasoactive |
| 02/11/2015 | CN104342473A 一种苋籽降血压活性肽制备及分离纯化方法 An amaranth seeds Preparation and Purification Method drop in blood pressure peptides |
| 02/11/2015 | CN104341489A 一类新的抑制新生血管的多肽及其应用 A new class of peptides inhibit angiogenesis and its application |
| 02/11/2015 | CN104341486A 一类新的抑制新生血管的多肽及其应用 A new class of peptides inhibit angiogenesis and its application |
| 02/11/2015 | CN104341482A 一种杂环磺酸衍生物的合成及其在药物治疗中的应用 Synthesis of a heterocyclic sulfonic acid derivatives and their use in drug therapy |
| 02/11/2015 | CN104341481A 一种磺酰胺化合物的合成和应用 Synthesis and Application of a sulfonamide compound |
| 02/11/2015 | CN104341450A 一种磺酰胺衍生物的合成与药学应用 Synthesis and Application of a pharmaceutically sulfonamide derivative |
| 02/11/2015 | CN104341438A 可形成具有(4,4)-拓扑结构的铜配位化合物及其制备方法与应用 May form a (4,4) - copper complex compound and its preparation method and application topologies |